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The incidence of Mycobacterium avium complex (MAC) 
infections among HIV-positive subjects has been 
greatly reduced in recent years from about 20% in 1994 
to about 4% in 1997 [l]. In the same year, in Italy the 
rate of disseminated MAC disease was 4.6% in patients 
with CD4 counts < 150 cells/mm3 and 8.3% in patients 
with CD4 counts <25 cells/mm3 [2]. Nonetheless, 
the need for an early diagnosis remains an urgent 
problem, since MAC infections are often associated 
with shortened survival, because treatment options are 
limited and responses to therapy may be incomplete or 
transient [3,4]. It has been reported that treatment of 
subjects with respiratory colonization may prevent 
dissemination [5], while other studies have shown the 
limited applicability of culture from respiratory and 
gastrointestinal tracts as a screening test to detect early 
MAC infections [6,7]. In this study, we evaluated the 
relationship between development of disseminated 
diseases and M. avium colonization of respiratory and 
gastrointestinal tracts in HIV-positive patients followed 
in our institute during 1995. 
Two hundred and four HIV-infected subjects 
followed at the Infectious Diseases wards of ‘L. Sacco’ 
Teaching Hospital of Milan were enrolled in the study. 
At the beginning of the study all patients had a CD4 
count > 200 cells/mm3 and were asymptomatic. Patients 
were excluded from the protocol if they had had 
previous mycobacterial infection or were undergoing 
treatment with antimycobacterial agents. Every patient 
had a CD4 count at the beginning of the study (time 
O), and had samples taken from blood, stools and 
sputum at time 0 and at 6, 12, 18 and 24 months. In 
this period no prophylactic treatment was given. 
Informed consent was obtained from all patients and 
the protocol had the approval of the Ethical Committee 
of our institution. 
Microscopic detection of acid-fast bacilli was 
executed for stools and sputum specimens according to 
a standard method (Kynioun method). For M. avium 
identification, samples were decontaminated, neutralized 
with phosphate buffer (0.075 mol/L, pH 6.8), and 
centrifuged. Lowenstein-Jensen (Oxoid, Unipath, 
Basingstoke, UK) slants were inoculated with sample 
sediment, incubated at 37°C for a maximum of 
2 months, and checked weekly for mycobacterial 
growth. Blood cultures were performed at each 
established time, or at any time for patients with either 
fever or clinical symptoms of mycobacterial infection. 
Blood was collected in an Isolator lysis-centrifugation 
tube (Merck, Darmstadt, Germany). After centri- 
fugation, supernatant was decanted and treated as 
described above. Once the culture was grown, M. 
aviurn was identified by commercial DNA probes 
(Gene-probe, San Diego, CA, USA). 
In the course of the study, three patients died 
from disseminated MAC infections. Figure 1 shows the 
distribution of M.  avium isolates in clinical samples. 
Twenty-two subjects out of 204 gave positive results for 
M. avium (10.8%): M. avium was isolated from blood in 
eight cases (36.4%), from sputum in five cases (22.7%), 
from stools in four cases (18.2%), from blood and stools 
in three cases (13.6%), and from blood and sputum in 
two cases (9.1%). All clinical specimens were subjected 
to a microscopic search for acid-fast bacilli: there were 
two positive stools smears among the seven positive 
stool cultures (28.6%), and no positive sputum smears 
among the seven positive sputum cultures. As far as the 
three stooldblood-positive patients are concerned, in 
one case the stool culture was found to be positive 1 
month before M.  avium recovery from blood, in 
another case the blood and stool cultures were positive 
at the same time, and in the third case the blood culture 
gave a positive result 1 month before the stool culture. 
The two sputum/blood-positive patients had positive 
blood cultures before M.  avium recovery in sputum: in 
one case 1 and 6 months before. 
At the times when positive results were obtained, 
CD4 values varied widely, ranging from 0 to 149 
cells/mm3 for positive blood, from 2 to 149 cells/mm3 
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Figure 1 Distribution of positive cultures with regard to 
the site of isolation of M .  avium. 
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for sputum, and from 10 to 48 cells/mm3 for stools: 
no relationship was seen between CD4 levels and 
occurrence of M .  avium colonization. 
Our data indicate that the incidence of MAC 
colonization in the gastrointestinal and respiratory 
tracts is rather low when compared with M.  avium 
isolation from blood. In our patients, positive blood 
culture for M.  avium was preceded by a positive stool 
culture in one and positive sputum cultures in two. 
However, these three subjects represent only 1.47% of 
the 204 HIV-positive subjects followed in this study. 
Moreover, M.  avium isolation from blood was not 
strictly related to development of colonization of the 
respiratory and gastrointestinal tracts, since only in 
few cases were positive cultures from blood followed 
by positive cultures from the respiratory and gastro- 
intestinal tracts. The observed incidence of M.  avium 
colonization in HIV-positive patients (10.8%) is some- 
what higher than that recently reported [1,2], but we 
have to consider that our study started in 1995, when 
new rifamycin and macrolide antibiotics and more 
active prophylaxis were not so widely used as in the 
following years. 
In conclusion, our study indicates that the low 
frequency of detection of the colonized state and 
the scarcity of information given by respiratory and 
gastro-intestinal specimens make the introduction of 
sputum and stool cultures unnecessary as screening for 
early diagnosis of disseminated MAC disease. 
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